Therapeutic Asset Ratings
464 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Acute Myeloid Leukemia
Mayo Clinic
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Angioimmunoblastic T-Cell Lymphoma
Mayo Clinic
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Plasma Cell Myeloma
Mayo Clinic
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Mayo Clinic
P1
CC
(43)
Recombinant Vesicular Stomatitis Virus-Expressing Interferon-Beta
T-Cell Non-Hodgkin Lymphoma
Mayo Clinic
P1
CC
(43)
rgv004
B-Cell Non-Hodgkin Lymphoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
P1
CC
(43)
Sgt-212
Friedreich Ataxia
Solid Biosciences Inc.
P1
CC
(43)
Sti-1386
Malignant Pancreatic Neoplasm
Sorrento Therapeutics, Inc.
P1
CC
(43)
Sti-1386
Hepatic Metastasis, Non-Human Animal
Sorrento Therapeutics, Inc.
P1
CC
(43)
Sxrn
Cachexia-Anorexia Syndrome
Jiangsu Nutai Biologics Co., Ltd
P1
CC
(43)
Transferrin Receptor-Targeted Liposomal P53 Cdna
Inflammatory Breast Carcinoma
Northwestern University
P1
CC
(43)
Vrp-Encapsulated Sarna Encoding Il-12
Head And Neck Squamous Cell Carcinoma
VLP Therapeutics
P1
CC
(43)
Vrp-Encapsulated Sarna Encoding Il-12
Head Neck Cancer
VLP Therapeutics
P1
CC
(43)
Vrp-Encapsulated Sarna Encoding Il-12
Mouth Disorder
VLP Therapeutics
P1
CC
(43)
Vrp-Encapsulated Sarna Encoding Il-12
Oral Cavity Carcinoma
VLP Therapeutics
P1
CC
(43)
Vrp-Encapsulated Sarna Encoding Il-12
Squamous Cell Carcinoma
VLP Therapeutics
P1
CC
(43)
Yuva-Gt-F901
Hemophilia B
Shenzhen Geno-Immune Medical Institute
P1
CC
(43)
hg302
Duchenne Muscular Dystrophy
HuidaGene Therapeutics Co., Ltd.
Early P1
CC
(43)
aav2/8-hlp-fviii-v3
Hemophilia A
University College, London
P1/2
CC
(43)
Adv/Hsv-Tk
Prostate Neoplasm
The Methodist Hospital Research Institute
P1/2
CC
(43)
Amt-162
Amyotrophic Lateral Sclerosis
UniQure Biopharma B.V.
P1/2
CC
(43)
asc618
Hemophilia A
ASC Therapeutics
P1/2
CC
(43)
bay2599023
Hemophilia A
Bayer
P1/2
CC
(43)
kxv01 tcr lentinvivo
Metastatic Malignant Neoplasm
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P1/2
CC
(43)
Raav2/5-Hnaglu
Hemophilia A
University College, London
P1/2
CC
(43)
Showing 301 to 325 of 464 assets
Previous
Page 13 of 19
Next
